期刊文献+

定州市慢性心力衰竭住院患者β-受体阻滞剂应用情况调查 被引量:5

Use of β-blockers in patients with chronic heart failure in Dingzhou
下载PDF
导出
摘要 目的了解定州市慢性心力衰竭患者应用β-受体阻滞剂的情况。方法对定州市3所医院住院的慢性心力衰竭患者病历进行回顾性调查分析。结果β-受体阻滞剂2006-2009年在慢性心力衰竭患者中使用率分别为18.78%、27.34%、43.90%和53.81%,总使用率为37.98%,有逐年增高趋势,医生在诊治慢性心力衰竭中,β-受体阻滞剂的无服药医嘱率有逐年下降趋势,心功能Ⅳ级患者β-受体阻滞剂长期服药率明显低于心功能Ⅲ级和Ⅱ级患者(P<0.05),服药过程中停药率均明显高于心功能Ⅲ级和Ⅱ级患者(P<0.05)。结论定州市慢性心力衰竭患者应用β-受体阻滞剂治疗比例较低,虽有逐年增加趋势,但尚需进一步加强。 Objective To investigation the use of β-blockers in patients with chronic heart failure in Dingzhou, Hebei Province. Methods Medical records of patients with chronic heart failure from 3 hospitals of Dingzhou were retrospectively analyzed. Results The usage rate of β-blockers in patients with chronic heart failure in 3 hospitals of Dingzhou was 18.78%, 27.34%, 43.90% and 53.81%, respectively in 2006-2009 with a total usage rate 37.98%, showing a yearly-increasing tendency. Physicians in diagnosis and treatment of patients with chronic heart failure found that the use of non-prescriptive oral β-blockers was declined year by year. The long-term use rate of β-blockers was significantly lower and the withdrawal rate of β-blockers was significantly higher in patients with cardiac function Ⅳ than in those with cardiac function Ⅱ and Ⅲ(P〈0.05). Conclusion The number patients with chronic heart failure in Dingzhou who use β-blockers is relatively low although the use of β-blockers tends to increase.
出处 《军医进修学院学报》 CAS 2011年第7期718-719,763,共3页 Academic Journal of Pla Postgraduate Medical School
关键词 心力衰竭 Β-受体阻滞剂 Heart Failure β -blockers
  • 相关文献

参考文献9

二级参考文献85

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2王林,马金萍,党群,陈康寅,李永健,李喜元,陈树涛,丛洪良,李广平,黄体钢.老年慢性心力衰竭住院患者2656例的回顾性分析[J].中华老年医学杂志,2006,25(8):565-569. 被引量:40
  • 3吴学思.正确掌握β受体阻滞剂在慢性心力衰竭的应用时机[J].中华心血管病杂志,2006,34(9):769-771. 被引量:62
  • 4郭静萱,李海燕.慢性心力衰竭的诊治进展[J].中国实用内科杂志,2007,27(1):11-13. 被引量:159
  • 5Lopez-Sendon J, Swedberg K, McMurray J, et al. The Task Force on Beta-Blockers of the European Society of Cardiology. Expert consensus document on β-adrenergic receptor blockers. Eur Heart J,2004,25:1341-1362.
  • 6Lopez-Sendon J, Swedberg K, McMurray J, et al. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J, 2004,25:1454-1470.
  • 7Packer M, Poole-Wilson PA, Armstrong PW, et al. On behalf of the ATLAS study group. Comparative effects of low and high doses of the angiotension-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation,1999,100:2312-2318.
  • 8The NETWORK investigators. Clinical outcome with enalapril in systematic chronic heart failure, a dose comparison. Eur Heart J,1998,19:481-489.
  • 9Pitt B, Poole-Wilson PA, Segl R. On behalf of the ELITE II investigators Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial - the Losartan Heart Failure Survival Study ELITE II. Lancet,2000,355:1582-1587.
  • 10Dickstein K, Kjekshus J, and the OPTIMAAL Steering Committee for the OPTIMAAL Study Group Effects of losartan and captopril on mortality and morbidity high -risk patients after acute myocardial infarction: the OPTIMAAL randomized trial. Lancet,2002,360:752-760.

共引文献6042

同被引文献26

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部